Abstract: The invention features compositions featuring (a) one or more of connective tissue growth factor (CTGF) and human C-terminal CTGF peptide; and (b) one or more of insulin and IGF-1; and methods of using such compositions to reduce cardiac tissue damage associated with an ischemic event or to enhance engraftment of a cell in a cardiac tissue.
Type:
Application
Filed:
January 25, 2023
Publication date:
September 14, 2023
Applicant:
The University of Vermont and State Agriculture College
Abstract: Compositions and methods are provided for determining platelet reactivity where the levels of Fc?RIIa on the surface of platelets is measured and if the levels of Fc?RIIa are greater than a reference value, the platelets have enhanced reactivity.
Type:
Grant
Filed:
October 30, 2019
Date of Patent:
September 5, 2023
Assignee:
University of Vermont And State Agriculture College
Abstract: The invention features compositions featuring (a) one or more of connective tissue growth factor (CTGF) and human C-terminal CTGF peptide; and (b) one or more of insulin and IGF-1; and methods of using such compositions to reduce cardiac tissue damage associated with an ischemic event or to enhance engraftment of a cell in a cardiac tissue.
Type:
Grant
Filed:
April 24, 2020
Date of Patent:
February 14, 2023
Assignee:
The University of Vermont and State Agriculture College
Abstract: Cryptosporidium is a leading contributor to early childhood mortality, and fully effective treatment for this important infectious disease is lacking. A bicyclic azetidine compound series is disclosed having potent in vitro activity against all C. parvum isolates tested, comparable potencies against C. hominis and C. parvum, and cured cryptosporidiosis in highly susceptible immunosuppressed mice with once-daily dosing.
Type:
Application
Filed:
October 23, 2020
Publication date:
January 12, 2023
Applicants:
The Broad Institute, Inc., President and Fellows of Harvard College, The University of Vermont and State Agriculture College
Inventors:
Eamon COMER, Bruno MELILLO, Christopher D. HUSTON
Abstract: As described herein, the present invention features compositions comprising an HGF/IgG complex and methods of using such compositions to reduce ischemic reperfusion injury.
Type:
Grant
Filed:
February 7, 2019
Date of Patent:
September 7, 2021
Assignee:
THE UNIVERSITY OF VERMONT AND STATE AGRICULTURE COLLEGE
Abstract: As described below, the present invention features methods for treating selected subjects at increased risk of a cardiovascular event, wherein the subjects are selected as having elevated platelet Fc?gamma RIIa.
Type:
Application
Filed:
April 16, 2019
Publication date:
July 29, 2021
Applicant:
The University of Vermont and State Agriculture College
Abstract: The invention features compositions featuring (a) one or more of connective tissue growth factor (CTGF) and human C-terminal CTGF peptide; and (b) one or more of insulin and IGF-1; and methods of using such compositions to reduce cardiac tissue damage associated with an ischemic event or to enhance engraftment of a cell in a cardiac tissue.
Type:
Application
Filed:
April 24, 2020
Publication date:
October 29, 2020
Applicant:
University of Vermont and State Agriculture College
Abstract: The invention features compositions featuring (a) one or more of connective tissue growth factor (CTGF) and human C-terminal CTGF peptide; and (b) one or more of insulin and IGF-1; and methods of using such compositions to reduce cardiac tissue damage associated with an ischemic event or to enhance engraftment of a cell in a cardiac tissue.
Type:
Grant
Filed:
June 14, 2017
Date of Patent:
June 9, 2020
Assignee:
University of Vermont and State Agriculture College
Abstract: Compositions and methods are provided for determining platelet reactivity where the levels of Fc?RIIa on the surface of platelets is measured and if the levels of Fc?RIIa are greater than a reference value, the platelets have enhanced reactivity.
Type:
Application
Filed:
October 30, 2019
Publication date:
May 28, 2020
Applicant:
University of Vermont And State Agriculture College
Abstract: The invention features compositions comprising agents having cardiac protective activity isolated from epicardial progenitor cells and derivatives thereof, and methods for the use of such compositions.
Type:
Grant
Filed:
January 29, 2018
Date of Patent:
April 28, 2020
Assignee:
THE UNIVERSITY OF VERMONT AND STATE AGRICULTURE COLLEGE
Abstract: Compositions and methods are provided for determining platelet reactivity where the levels of Fc?RIIa on the surface of platelets is measured and if the levels of Fc?RIIa are greater than a reference value, the platelets have enhanced reactivity.
Type:
Grant
Filed:
May 23, 2013
Date of Patent:
December 10, 2019
Assignee:
The University of Vermont And State Agriculture College
Abstract: As described herein, the present invention features compositions comprising an HGF/IgG complex and methods of using such compositions to reduce ischemic reperfusion injury.
Type:
Application
Filed:
February 7, 2019
Publication date:
July 25, 2019
Applicant:
The University of Vermont and State Agriculture College
Abstract: As described herein, the present invention features compositions comprising an HGF/IgG complex and methods of using such compositions to reduce ischemic reperfusion injury.
Type:
Grant
Filed:
February 23, 2016
Date of Patent:
March 26, 2019
Assignee:
The University of Vermont and State Agriculture College
Abstract: Featured is a method for assessing risk of a patient condition. Such a method includes providing criteria that relate predetermined parameters to each other, inputting observations into given criterion and relating observations of one or more acquired parameters, and converging the given criterion so as to provide an output representative of a patient condition. Such a method further includes translating the output into a visual form such as displaying the output on a display device.
Type:
Grant
Filed:
December 26, 2012
Date of Patent:
January 29, 2019
Assignee:
The University of Vermont and State Agriculture College
Inventors:
Kathleen B. Ziedins, Christopher M. Danforth, Thomas Orfeo, Stephen J. Everse, Kenneth G. Mann
Abstract: As described herein, the present invention features compositions comprising an HGF/IgG complex and methods of using such compositions to reduce ischemic reperfusion injury.
Type:
Application
Filed:
February 23, 2016
Publication date:
August 23, 2018
Applicant:
The University of Vermont and State Agriculture College
Abstract: The invention features compositions comprising agents having cardiac protective activity isolated from epicardial progenitor cells and derivatives thereof, and methods for the use of such compositions.
Type:
Application
Filed:
January 29, 2018
Publication date:
August 16, 2018
Applicant:
THE UNIVERSITY OF VERMONT AND STATE AGRICULTURE COLLEGE
Abstract: The invention features compositions featuring (a) one or more of connective tissue growth factor (CTGF) and human C-terminal CTGF peptide; and (b) one or more of insulin and IGF-1; and methods of using such compositions to reduce cardiac tissue damage associated with an ischemic event or to enhance engraftment of a cell in a cardiac tissue.
Type:
Application
Filed:
June 14, 2017
Publication date:
May 24, 2018
Applicant:
University of Vermont and State Agriculture College
Abstract: The invention features compositions comprising agents having cardiac protective activity isolated from epicardial progenitor cells and derivatives thereof, and methods for the use of such compositions.
Type:
Grant
Filed:
August 14, 2015
Date of Patent:
March 13, 2018
Assignee:
THE UNIVERSITY OF VERMONT AND STATE AGRICULTURE COLLEGE
Abstract: The invention features compositions featuring (a) one or more of connective tissue growth factor (CTGF) and human C-terminal CTGF peptide; and (b) one or more of insulin and IGF-1; and methods of using such compositions to reduce cardiac tissue damage associated with an ischemic event or to enhance engraftment of a cell in a cardiac tissue.
Type:
Grant
Filed:
March 7, 2014
Date of Patent:
July 18, 2017
Assignee:
University of Vermont and State Agriculture College
Abstract: Methods for diagnosing and treating conditions associated with life-threatening neurological complications are provided. The methods involve in some aspects the identification of oxLDL and LOX-1 as critical players in pregnant subjects and in some cases subjects having severe preeclampsia (early onset preeclampsia). Related products and kits are also provided.
Type:
Grant
Filed:
October 3, 2013
Date of Patent:
February 14, 2017
Assignee:
The University of Vermont and State Agriculture College